CLOSING BELL: This was the first gain for benchmark indices in seven days
India-UAE on February 18 signed the comprehensive economic partnership agreement with a view to boosting bilateral trade in goods to USD 100 billion over a 5 year period and creation of lakhs of jobs
The market breadth was positive, with 1,955 stocks advancing and 1,404 declining
While the global index provider hasn't added or deleted any Indian stocks, it has reduced weights of bluechip firms RIL, Infosys and HDFC
Snapping out of last month's underperformance, the domestic markets delivered returns better than its global peers
India's hospitality industry witnessed a decline of 38.7% in revenue per available room (RevPAR) during Q1 2021 as compared to Q1 2020
In an Q&A, Saugata Gupta, Marico's managing director and CEO, hails the Budget and lays out the company's road map for the future
While both have seen a drop in external trade in relation to GDP, the reasons are quite different - in China it is in part a problem of success, in India it points more to failure, writes T N Ninan
Foreign investor body writes to the market regulator highlighting operational difficulties
2020 underperformance narrows; Experts say going further outperformance could be a challenge
Ind-Ra said it expects sugar production to increase to 30.5 million tonnes in SS21, factoring in a cane diversion equivalent to 1.5 million tonnes of sugar
The objective is to make India self reliant in production of 53 critical Active Pharmaceutical Ingredients, and in production of medical devices, for which India is crucially dependent on imports
Rossari is the first IPO to hit the domestic markets since a national lockdown was declared in early-March.
Some believe that the best monthly performance in 11 years was on a weak footing, as it was sans any fundamental base
Pharma firms can build brands and enjoy higher margins here
The pharma sector, once considered a safe bet, has been trailing the benchmark indices for four years in a row
Indian indices fall 4%; gloom prevails in other global markets also after Trump's dire warning
The Sensex ended 62 points higher at 35,697, while the Nifty ended little changed at 10,458
The decadal average of funds raised through this route is currently at its lowest on record
Big pharma companies, however, said while it was true that formulation players would not rush to buy raw material, they could not afford losing customers.